CD44 and neoplasm: The CD44 antigen has been traditionally used in liquid biopsy as lead marker to identify tumor-derived epithelial circulating tumor stem cells based on its association with multi-lineage differentiation and the potential of self-renewal (Theodoropoulos et al. 2010).